Like diabetes and hypertension, obesity is not cured, its controlled, says New York City-based endocrinologist and obesity medicine specialist Dr
Shoji M, Iwakami N, Takeuchi S, Waragai M, Suzuki M, Kanazawa I, et al
Mike Haney: I want to come back to all of those other potential benefits what that means for again that question of who are these for but just to, I'm curious, as I've watched this: we talk about sort of harnessing the satiating hormones
Individual ingredients are FDA-recognized as safe
Strategic Implications If validated in prospective randomized trials, GLP-1 receptor agonists could: Represent an adjunctive strategy in obesity-associated asthma Expand the therapeutic footprint of GLP-1s beyond metabolic disease Influence treatment guidelines in high-BMI asthma populations Given the rapid adoption of GLP-1 therapies globally, further investigation into respiratory benefits could have significant clinical and commercial implications